Company Filing History:
Years Active: 2023-2025
Title: Innovations by Inventor Paul Bartel: Advancements in Brain Tissue Diagnostics
Introduction: Paul Bartel, an inventive mind based in Woburn, MA, has contributed significantly to the field of diagnostic technology. With two patents to his name, Bartel focuses on non-invasive methods for understanding brain tissue health, particularly in the context of neurodegenerative conditions.
Latest Patents: Bartel's latest patents include a groundbreaking diagnostic system that allows for the simultaneous detection of light at multiple locations within a spectroscopic framework. This device is specifically designed for non-invasively measuring wavelength-dependent changes in the optical absorption of brain tissue affected by conditions such as Chronic Traumatic Encephalopathy (CTE), Traumatic Brain Injury (TBI), concussions, and Lou Gehrig's disease.
The system utilizes light sources that trans-cranially illuminate the brain and the tissues surrounding it in low-absorption spectral windows of the visible and near-infrared spectrum. Optodes are strategically placed at predetermined distances from the light source to collect signals that are scattered and/or deflected from the surface of the head. This distance is crucial as it correlates with the depth of tissue penetration for the collected light. A spectrometer and computer analyze these signals to identify characteristic optical signatures indicative of brain damage, providing valuable diagnostic information in vivo.
Career Highlights: Throughout his career, Paul Bartel has been instrumental in advancing medical diagnostic technologies. His prominent position at Headwall Photonics, Inc. highlights his capabilities in leveraging photonics to develop innovative solutions that address critical medical challenges.
Collaborations: Bartel's work is complemented by collaborations with notable professionals like Domhnull Granquist-Fraser and Carson Roberts. Together, they contribute to the development and refinement of diagnostic systems that enhance patient care through improved understanding of brain health.
Conclusion: Paul Bartel's contributions are essential for the advancement of diagnostic technologies aimed at understanding and treating brain injuries and diseases. His innovative patents showcase the intersection of technology and medicine, underscoring the importance of non-invasive methods in improving patient outcomes. As he continues to work with his colleagues at Headwall Photonics, Bartel remains a key player in the evolution of diagnostic systems for critical health challenges.